轻度认知障碍受试者阿尔茨海默病生物标志物状态的披露。 - Suppr

Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment.

作者信息

Visser Pieter Jelle, Wolf Henrike, Frisoni Giovanni, Gertz Hermann-Josef

出版信息

Biomark Med. 2012 Aug;6(4):365-8. doi: 10.2217/bmm.12.58.

DOI:10.2217/bmm.12.58

PMID:22917137

Abstract

摘要

相似文献

Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment.

Biomark Med. 2012 Aug;6(4):365-8. doi: 10.2217/bmm.12.58.

New diagnostic criteria for Alzheimer's disease.

Biomark Med. 2011 Aug;5(4):407-9. doi: 10.2217/bmm.11.46.

The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.

Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006. Epub 2014 Aug 20.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease.

Biomark Med. 2011 Aug;5(4):411-3. doi: 10.2217/bmm.11.50.

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.

Neurobiol Aging. 2013 Aug;34(8):2003-13. doi: 10.1016/j.neurobiolaging.2013.02.002. Epub 2013 Mar 27.

Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.

J Alzheimers Dis. 2012;29(3):641-8. doi: 10.3233/JAD-2012-111703.

Alzheimer's disease biomarker development: a call to funding bodies.

Neurobiol Aging. 2017 Apr;52:117-118. doi: 10.1016/j.neurobiolaging.2016.02.035.

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.

Alzheimers Dement. 2014 Nov;10(6):808-17. doi: 10.1016/j.jalz.2014.03.003. Epub 2014 Aug 20.

Amyloid biomarkers in Alzheimer's disease.

Trends Pharmacol Sci. 2015 May;36(5):297-309. doi: 10.1016/j.tips.2015.03.002. Epub 2015 Apr 1.

引用本文的文献

Counseling and disclosure practices in predictive Alzheimer's disease diagnostics: A scoping review.

Alzheimers Dement. 2024 Dec;20(12):8910-8936. doi: 10.1002/alz.14365. Epub 2024 Nov 19.

Psychological outcomes of dementia risk estimation in MCI patients: Results from the PreDADQoL project.

Alzheimers Dement. 2024 Nov;20(11):7635-7656. doi: 10.1002/alz.14226. Epub 2024 Oct 1.

Online clinical tools to support the use of new plasma biomarker diagnostic technology in the assessment of Alzheimer's disease: a narrative review.

Brain Commun. 2023 Nov 24;5(6):fcad322. doi: 10.1093/braincomms/fcad322. eCollection 2023.

European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment.

Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.

What patients want to know, and what we actually tell them: The ABIDE project.

Alzheimers Dement (N Y). 2020 Dec 16;6(1):e12113. doi: 10.1002/trc2.12113. eCollection 2020.

ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics.

Alzheimers Res Ther. 2019 Aug 31;11(1):77. doi: 10.1186/s13195-019-0531-y.

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey.

Alzheimers Res Ther. 2019 Aug 22;11(1):74. doi: 10.1186/s13195-019-0525-9.

Review of the Ethical Issues of a Biomarker-Based Diagnoses in the Early Stage of Alzheimer's Disease.

J Bioeth Inq. 2018 Jun;15(2):219-230. doi: 10.1007/s11673-018-9844-y. Epub 2018 Mar 12.

Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.

J Alzheimers Dis. 2018;62(2):487-498. doi: 10.3233/JAD-170813.

Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.

Alzheimers Res Ther. 2017 Dec 2;9(1):92. doi: 10.1186/s13195-017-0321-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献